Streetbeat News

Stock Prices

DELL

NXTV

TSLA

WLDR

The Delaware Supreme Court upheld a $267 million legal fee for securing a $1 billion settlement for Dell Technologies shareholders. This ruling could impact similar cases involving Tesla. Dell shares are trading higher premarket. The fee is the second largest in Delaware and fifth largest in federal securities litigation. Tesla is contesting substantial legal fees in other cases.

Portfolio Pulse from Lekha Gupta

August 15, 2024 | 1:11 pm

TVGN

Tevogen Bio Holdings (NASDAQ:TVGN) reported a Q2 EPS of $(0.04), showing a significant improvement from $(0.18) per share in the same period last year, marking a 77.78% increase.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 1:09 pm

GILD

The FDA has granted accelerated approval for Gilead Sciences' (NASDAQ:GILD) drug Livdelzi (seladelpar) for treating primary biliary cholangitis (PBC). This approval follows Gilead's $4.3 billion acquisition of CymaBay Therapeutics. The approval is based on Phase 3 study data showing significant improvements in patients. However, continued approval is contingent on further clinical trials. Gilead's stock was down 0.04% in premarket trading.

Portfolio Pulse from Vandana Singh

August 15, 2024 | 1:09 pm

ARM

ARM shares are trading higher after Elliott Management added to its position in the company.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 1:08 pm

GAUZ

Gauzy expects aggregated revenue of $240M over the next 10 years from aeronautic cockpit shading. New wins in Q2 2024 have increased Gauzy's market share to 95% in commercial aircraft and business jets. The company is well-positioned to expand in the $600M annual aircraft shading and lighting market.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 1:08 pm

SHIBUSD

Shiba Inu's (SHIB) burn rate has dropped by 45% in the last two days, causing concern among traders. Despite this, the Shiba community launched ShibHub, an app to enhance the Shiba ecosystem. Technical indicators show mixed signals, with RSI close to bearish levels but potential bullish momentum if certain moving averages cross.

Portfolio Pulse from Khyathi Dalal

August 15, 2024 | 1:07 pm

PGR

The Progressive Corporation (NYSE:PGR) reported strong financial results for July, with earnings of $1.38 per share and net premiums written of $6.378 billion. Following the announcement, Progressive shares rose by 5.4% to close at $234.34. Analysts from Goldman Sachs, Piper Sandler, and Wells Fargo have increased their price targets for the stock.

Portfolio Pulse from Avi Kapoor

August 15, 2024 | 1:05 pm

CYTH

Cyclo Therapeutics (NASDAQ:CYTH) reported Q2 earnings per share (EPS) of $(0.21), missing the analyst estimate of $(0.16) by 31.25%. Sales were $123.10K, missing the estimate of $267.50K by 53.98%. Despite the misses, EPS improved by 36.36% and sales increased by 5.11% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 1:03 pm

SPCB

SuperCom reported Q2 2024 adjusted EPS of $0.09, significantly beating the estimate of $(0.03). Sales for the quarter were $7.545 million, also surpassing the $6.000 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 1:02 pm

SIGA

The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) announced that SIGA Technologies' antiviral tecovirimat did not meet its primary endpoint in a study for treating monkeypox virus in the Democratic Republic of the Congo. The study showed no statistically significant improvement in lesion resolution within 28 days. SIGA's stock dropped 38.3% following the news.

Portfolio Pulse from Vandana Singh

August 15, 2024 | 1:01 pm